Gilead Sciences, Inc. (NASDAQ:GILD)

CAPS Rating: 4 out of 5

A biopharmaceutical company that discovers, develops and commercializes innovative therapeutics in areas of unmet medical need.

Recs

1
Player Avatar ajcmr3 (92.22) Submitted: 1/29/2013 7:32:57 PM : Outperform Start Price: $39.97 GILD Score: +28.97

HCV Franchise adds significant growth potential going into 2014

Report this Post Reply

Featured Broker Partners


Advertisement